Abstract
DEVELOPMENT OF CHROMATOGRAPHIC METHOD FOR THE DETERMINATION OF FAVIPIRAVIR FROM BULK DRUG AND TABLET DOSAGE FORM

*Anamika Damodare and Rajashri D. Ingale

ABSTRACT

The aim of study is to develop and validate a new, simple, rapid, precise, and accurate An Eco-friendly RP-HPLC and UV-Method Development and Validation for an estimation of Favipiravir in Bulk and pharmaceutical dosage form. To perform all the validation parameters according to ICH guidelines. To Optimize the validated parameters. FAV belongs to class II in the Biopharmaceutics Classification System (BCS). High permeability and low water solubility. To develop and validate a new, simple, rapid, precise, and accurate An Eco-friendly RP-HPLC and UV-Method Development and Validation for an estimation of Favipiravir in Bulk and pharmaceutical dosage form. To perform all the validation parameters according to ICH guidelines. To Optimize the validated parameters. Method development was done by using column (Cosmosil) C18 column (250 mm X 4.6 mm i.d.) 5μm, mobile phase Methanol: 0.2% Glacial acetic acid (pH 3.00) (20:80 % v/v), flow rate 0.5 ml/min, sample size 20 ml, run time 5 min. Validation parameters like accuracy, precision, repeatabilitystudies, specificity, solubility, LOD, LOQ and stability testing was performed on Favipiravir. From the calibration curve it was concluded that the Favipiravir shows linear response in the range of 2.0-30.0 μg /ml. All the parameters were within range hence above method is validated.

Keywords: Favipiravir, HPLC, Accuracy, stability, specificity, linearity, filtration etc.


[Full Text Article]   [Download Certificate]

Indexing

Best Article Awards

European Journal of Biomedical and Pharmaceutical Sciences (EJBPS) is giving Best Article Award in every Issue for Best Article and Issue Certificate of Appreciation to the Authors to promote research activity of scholar.

Best Article of current issue :

Dr. Dhrubo Jyoti Sen

Download Article : Click here

News & Updation

  • EJBPS: MARCH ISSUE PUBLISHED

    MARCH 2026 Issue has been successfully launched on 1 MARCH 2026.

  • EJBPS: New Impact Factor 2026

    EJBPS Impact Factor has been Increased from  7.482 to 8.181 for Year 2026.

  • Index Copernicus Value

    EJBPS Received Index Copernicus Value 77.3, due to High Quality Publication in EJBPS at International Level

  • Journal web site support Internet Explorer, Google Chrome, Mozilla Firefox, Opera, Saffari for easy download of article without any trouble.

    .

  • Article Invited for Publication

    Dear Researcher, Article Invited for Publication  in EJBPS coming Issue.

     

Google Scholar Index Copernicus Indian Science Publications Urlich's Periodicals Directory, Proquest, UK (In Process) Research Bible, Fuchu, Tokyo. JAPAN UDLedge Science Citation Index International Society for Research activity (ISRA) Scientific Indexing Services (SIS) InfoBase Index (In Process) SJIF Impact Factor Scholar Article Impact Factor, SAIF Universal Impact Factor CAS (A Division of American Chemical Society) USA (Under Process) Directory of Open Access Journal (DOAJ, Sweden, in process) CiteFactor Directory Of Research Journal Indexing (DRJI) Indian citation Index (ICI) Journal Index (JI, Under Process) Directory of abstract indexing for Journals (DAIJ) Open Access Journals (Under Process) Impact Factor Services For International Journals (IFSIJ) Cosmos Impact Factor Jour Informatics (Under Process) Eurasian Scientific Journal Index (ESJI) International Innovative Journal Impact Factor (IIJIF) Science Library Index, Dubai, United Arab Emirates Global Impact Factor (GIF) (0.377) IP Indexing (IP Value 3.77) Web of Science Group (Under Process) Directory of Research Journals Indexing Scope Database Academia Academia Doi-Digital Online Identifier Doi-Digital Online Identifier ISSN National Centre Zenodo Indexing International CODEN Service, USA

UG/PG/Ph.D Research Publication

Research Scholar of UG/PG/Ph.D can Submit their Research Article/Review Article/Case Study/Short Communication for Publication in EJBPS

Downloads

Copyright From

Covering Letter

                        Author Instruction 
 

PLAGERLUM REPORT